Lexington, Kentucky 40536


Purpose:

Baseline self-report outcome measures will be completed and additional assessments will occur mid-treatment , post-treatment , 3 months following completion of all sessions, and 6 months following completion of all sessions. Patients and therapists will complete the evaluation measures in private (at home, in an office). At the University of Kentucky Markey Cancer Center, BBI treatment is offered in group and individual formats. The course of individual treatment varies and group treatment consists of 10 1.5-hour weekly sessions in the "intensive" phase, followed by 2 1.5-hour bi-weekly maintenance sessions. Individual treatment is one-on-one. In group treatment, there are typically 6-12 patients per group and 1 or 2 therapists. The intervention helps patients to learn adaptive coping strategies and how to apply them to daily stressors. Additional content discusses use of seeking information, enhancing social support, enhancing body esteem and intimacy, and maintaining positive changes.


Criteria:

Inclusion Criteria: - Females - Stage I-IV gynecologic cancer (including ovarian, uterine, cervical, vulvar, or vaginal cancer) - Undergoing active treatment or in remission and undergoing active surveillance; age ≥21 and ≤80 - Able to speak/read English. Exclusion Criteria: - Concurrent diagnosis of organic brain syndrome, dementia, mental retardation - Non-English speaking, or significant sensory deficit - Major mental illness (e.g., schizophrenia, psychotic disorder).


NCT ID:

NCT02454036


Primary Contact:

Principal Investigator
Rachel Miller, MD
University of Kentucky

Rachel Miller, MD
Phone: 859-323-2169
Email: raware00@uky.edu


Backup Contact:

Email: joan.scales@uky.edu
Joan Scales, MSSW, LCSW
Phone: (859) 323-1403


Location Contact:

Lexington, Kentucky 40536
United States

Rachel Miller, MD
Phone: 859-323-2196
Email: raware00@uky.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.